Analysis of Five Nitrosamine Impurities in Drug Products and Drug Substances Using Agilent GC/MS/MS Instrumentation
Applications | 2020 | Agilent TechnologiesInstrumentation
GC/MSD, GC/MS/MS, GC/QQQ
IndustriesPharma & Biopharma
ManufacturerAgilent Technologies
Key wordsrelative, responses, ndba, neipa, ndipa, ndma, otr, ndea, std, fda, counts, concentration, acquisition, drug, impurities, loqs, were, dichloromethane, min, angiotensin, area, time, loq, includingvalsartan, temperature, method, all, iireceptor, arbs, quadrupole, injection, olmesartan, along, attaining, performed, products, churley, recalls, announced, ambiguous, substances, sartan, using, recalled, melissa, irbesartan, unit, losartan, mode, blockers
Similar PDF
Quantification of Nitrosamine Impurities in Metformin Using Agilent GC/MS/MS Instrumentation
2020|Agilent Technologies|Applications
Application Note Pharma and Biopharma Quantification of Nitrosamine Impurities in Metformin Using Agilent GC/MS/MS Instrumentation Authors Soma Dasgupta, Vivek Dhyani, Samir Vyas, and Melissa Churley, Agilent Technologies, Inc. Abstract Since June 2018, several drugs were recalled due to the presence…
Key words
ndma, ndmandea, ndeacounts, countsacquisition, acquisitiondrug, drugname, namendba, ndbanitrosamine, nitrosaminemin, minneipa, neipandipa, ndipaweighed, weighedϭϭϯ, ϭϭϯїϱϲ͘ϭ͕, їϱϲ͘ϭ͕time
Nitrosamine Impurities Application Guide - Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products
2020|Agilent Technologies|GuidesPresentations
Nitrosamine Impurities Application Guide Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products Sartan-Based Losartan Valsartan Candesartan Telmisartan Metformin Ranitidine Nitrosamines are formed by chemical reactions that occur during API manufacturing whether from starting materials, intermediates, reactants, reuse…
Key words
back, backndma, ndmaneipa, neipafda, fdandipa, ndipandea, ndeandba, ndbametformin, metforminnitrosamine, nitrosamineintroduction, introductionapi, apivalsartan, valsartanbest, bestquant, quantdichloromethan
Nitrosamines Analysis in Pharmaceuticals - Consumables workflow ordering guide
2021|Agilent Technologies|Guides
Nitrosamines Analysis in Pharmaceuticals Using Single Quadrupole GC/MS or Triple Quadrupole GC/MS Consumables workflow ordering guide R1 N N R2 R O 2 R 1 R N N 2 R 1 R O R 2 1 N N N N…
Key words
nitrosamine, nitrosaminenitrosamines, nitrosaminesndma, ndmandea, ndeamylist, mylistfavorite, favoriteneipa, neipandipa, ndipadrug, drugppm, ppmitems, itemsinlet, inletclick, clickreplacement, replacementsupplies
Screening of Nitrosamine Impurities in Drug Products and Drug Substances Using Agilent GC/MS/MS Instrumentation
2023|Agilent Technologies|Applications
Application Note Pharma & Biopharma Screening of Nitrosamine Impurities in Drug Products and Drug Substances Using Agilent GC/MS/MS Instrumentation Authors Abstract Carole Antoine, Milan Macé, Elodie Barrau, and Emmanuel Desmartin Eurofins Amatsi Analytics This application note highlights a comprehensive solution…
Key words
ndph, ndphnmpea, nmpeanmpa, nmpanitrosamines, nitrosaminesnmor, nmornmea, nmeanpyr, npyrnpip, npipndma, ndmaneipa, neipandipa, ndipandpa, ndpandba, ndbandea, ndeanitrosamine